Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain.

A ferocious surge of flu cases is linked in part to a variant that has not been dominant in the past few years — resulting in ...

The mucosal surfaces that line the body are embedded with defensive molecules that help keep microbes from causing ...

Have you ever wanted the calm and recovery of an infrared sauna, but you hate the blast-furnace feel of a traditional ...

Scientists have identified a promising target for treatment of a devastating autoimmune disease affecting the brain.

Sadly, there is no cure for Huntington’s disease. But a couple new research papers suggests this may be about to change.

A wider public conversation has arisen over whether it's time for a shift in how we think about categories of autism, amid ...

Beyond Air (XAIR) stock surged 150% as XTL acquired 85% of NeuroNOS for $32.5M. Trading volume jumped 363% on autism treatment platform deal.

Among the most famous demonstrations of genetic mutations driving infection outcome is severe combined immunodeficiency (SCID ...

In a significant effort to speed up diagnosis of serious infections - a move that experts say could also help reduce ...

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

About XTL Biopharmaceuticals Ltd. XTL is an IP Portfolio company that holds 100% of The Social Proxy Ltd. and IP portfolio including hCDR1 for Lupus (SLE) and Sjögren's Syndrome (SS) that the company ...